Prosecution Insights
Last updated: April 19, 2026

Squire Pb (Sutro Biopharma)

7 pending office actions • 2 clients

Portfolio Summary

7
Total Pending OAs
3
Final Rejections
4
Non-Final OAs

Client Portfolio (2 clients)

Client (Assignee)Pending OAs
Sutro Biopharma, Inc. 6
Fred Hutchinson Cancer Center 1

Pending Office Actions

App #TitleClientExaminerArt UnitStatusFiled
18638420 ANTI-BCMA ANTIBODIES AND TREATMENT METHODS Sutro Biopharma, Inc. KAUFMAN, CLAIRE M 1674 Final Rejection Apr 17, 2024
18491656 ANTI-FOLATE RECEPTOR CONJUGATE THERAPY FOR CANCER TREATMENT Fred Hutchinson Cancer Center ALFANO, ALAN 1641 Non-Final OA Oct 20, 2023
18357956 ANTI-CD74 ANTIBODY CONJUGATES, COMPOSITIONS COMPRISING ANTI CD74 ANTIBODY CONJUGATES AND METHODS OF USING ANTI-CD74 ANTIBODY CONJUGATES Sutro Biopharma, Inc. HOWARD, ZACHARY C 1674 Non-Final OA Jul 24, 2023
18357966 ANTIBODIES WITH ENGINEERED CH2 DOMAINS, COMPOSITIONS THEREOF AND METHODS OF USING THE SAME Sutro Biopharma, Inc. LU, CHENG 1642 Final Rejection Jul 24, 2023
18215093 BETA-GLUCURONIDE LINKER-PAYLOADS, PROTEIN CONJUGATES THEREOF, AND METHODS THEREOF Sutro Biopharma, Inc. GALSTER, SAMUEL LEONARD 1693 Non-Final OA Jun 27, 2023
17908882 ANTIBODIES COMPRISING SITE-SPECIFIC GLUTAMINE TAGS, METHODS OF THEIR PREPARATION AND METHODS OF THEIR USE Sutro Biopharma, Inc. HUYNH, PHUONG N 1641 Final Rejection Sep 01, 2022
17727395 ANTIBODIES COMPRISING MULTIPLE SITE-SPECIFIC NON-NATURAL AMINO ACID RESIDUES, METHODS OF THEIR PREPARATION AND METHODS OF THEIR USE Sutro Biopharma, Inc. HUYNH, PHUONG N 1641 Non-Final OA Apr 22, 2022

Managing Squire Pb (Sutro Biopharma)'s Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month